TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Ajanta Pharma Limited ( (IN:AJANTPHARM) ) is now available.
Ajanta Pharma Limited has announced that it will release its audited financial results for the fourth quarter of the fiscal year 2025 on April 30, 2025. The company will host an earnings conference call on the same day, where the leadership team will discuss the financial performance and engage with stakeholders through a Q&A session. This announcement is significant for stakeholders as it provides insights into the company’s financial health and strategic direction.
More about Ajanta Pharma Limited
Ajanta Pharma Limited is a pharmaceutical company based in Mumbai, India. It specializes in the development, manufacturing, and marketing of pharmaceutical products, focusing on branded generics in therapeutic segments such as anti-malarial, cardiology, dermatology, and ophthalmology. The company serves markets across India, Asia, Africa, and the United States.
YTD Price Performance: -10.81%
Average Trading Volume: 4,596
Current Market Cap: 334.5B INR
See more data about AJANTPHARM stock on TipRanks’ Stock Analysis page.